Douleur et métastases osseuses

25 novembre 2008

Auteurs : J. Wassermann, B. De La Lande, A. Pecking, L. Brasseur
Référence : Prog Urol, 2008, 18, S399, suppl. S7


Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser






Schwei M.J., Honore P., Rogers S.D., et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain J Neurosci 1999 ;  19 : 10886-10897
Honore P., Rogers S.D., Schwei M.J., et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons Neuroscience 2000 ;  98 (3) : 585-598 [cross-ref]
Sabino M.A., Luger N.M., Mach D.B., et al. Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system International Journal of Cancer 2003 ;  104 : 550-558 [cross-ref]
Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain Science 2000 ;  288 : 1765-1769 [cross-ref]
Sato S., Futakuchi M., Ogawa K., et al. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment Cancer Science 2008 ;  99 : 316-323 [cross-ref]
Alarmo E.L., Korhonen T., Kuukasjarvi T., et al. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas Annals Oncology 2008 ;  19 : 308-314 [cross-ref]
Luger N.M., Mach D.B., Sevcik M.A., Mantyh P.W. Bone cancer pain: from model to mechanism to therapy J Pain Symptom Manage 2005 ;  29 : S32-46 [cross-ref]
Peters C.M., Ghilardi J.R., Keyser C.P., et al. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain Experimental Neurology 2005 ;  193 : 85-100 [cross-ref]
Martin C.D., Jimenez-Andrade J.M., Ghilardi J.R., Mantyh P.W. Organization of a unique net-like meshwork of CGRP+ sensory fibers in the mouse periosteum: implications for the generation and maintenance of bone fracture pain Neurosci Lett 2007 ;  427 : 148-152 [inter-ref]
Zhang F., Lu W., Dong Z. Tumor-infiltrating macrphages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice Clin Cancer Res 2002 ;  8 : 2942-2951
Poon R.T., Fan S.T., Wong J. Clinical implications of circulating angiogenic factors in cancer patients J Clin Oncol 2001 ;  19 : 1207-1225 [cross-ref]
Mundy G.R. Metastases to bone: causes, consequences, and therapeutic opportunities Nat Rev Cancer 2002 ;  2 : 584-593 [cross-ref]
Mercadante S. Malignant bone pain: pathophysiology and treatment Pain 1997 ;  69 : 1-18 [cross-ref]
Honoré P., Schwei J., Rogers S.D., et al. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog Brain Res 2000 ;  129 : 389-397
Yamamoto J., Kawamata T., Niiyama Y., et al. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murin model of bone cancer pain Neuroscience 2008 ;  151 : 843-853 [cross-ref]
Luger N.M., Sabino M.A., Schwei M.J., et al. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain Pain 2002 ;  99 : 397-406 [cross-ref]
King T., Vardanyan A., Majuta L., et al. Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer Pain 2007 ;  132 : 154-168 [cross-ref]
Porreca F., Ossipov M.H., Gebhart G.F. Chronic pain and medullary descending facilitation Trends in Neurosciences 2002 ;  25 : 319-325 [cross-ref]
Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia Nature Neuroscience 2007 ;  10 (11) : 1361-1368 [cross-ref]
Woolf C.J. Central sensitization: uncovering the relation between pain and plasticity Anesthesiology 2007 ;  106 : 864-867 [cross-ref]
Khasabov S.G., Hamamoto D.T., Harding-Rose C., Simone D.A. Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain Brain Research 2007 ;  1180 : 7-19 [cross-ref]
Donovan-Rodriguez T., Dickenson A.H., Urch C.E. Gabapentin Normalizes Spinal Neuronal Responses That Correlate with Behavior in a Rat Model of Cancer-induced Bone Pain Anesthesiology 2005 ;  102 : 132-140 [cross-ref]
Urch C.E., Donovan-Rodriguez T., Dickenson A.H. Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain Pain 2003 ;  106 : 347-356 [cross-ref]
Abrams H.L., Spiro R., Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases Cancer 1950 ;  3 : 74-85 [cross-ref]
Vainio A., Auvinen A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study Symptom Prevalence Group J Pain Symptom Manage 1996 ;  12 (1) : 3-10 [cross-ref]
Janjan N.A., Payne R., Gillis T., et al. Presenting factors in patients referred to a multidisciplinary clinic for bone metastasis J Pain Symptom Manage 1998 ;  16 : 171-178 [cross-ref]
Holtan A., Aass N., Nordoy T., et al. Prevalence of pain in hospitalised cancer patients in Norway: a national survey Palliative Medicine 2007 ;  21 : 7-13 [cross-ref]
van den Beuken-van Everdingen M.H.J., de Rijke J.M., et al. High prevalence of pain with cancer in a large population-based study in The Netherlands Pain 2007 ;  132 : 312-320 [cross-ref]
Katagiri H., Takahashi M., Inagaki J. Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study Cancer 1999 ;  86 (3) : 533-537 [cross-ref]
Coleman R.E. Skeletal Complications of Malignancy Cancer 1997 ;  80 (8) : 1588-1594 [cross-ref]
Hoskin P.J. Management of bone pain Clinical pain management London: Cancer Pain. Arnold (2003).  281-292
Cherny N. The Assesment of Cancer Pain. In Wall P, Melzack R (eds) Textbook of Pain Online Section 8, Ch.70. Elsevier 2008.(content).
Larue F., Colleau S.M., Brasseur L., Cleeland E.S. Multi-centre study of cancer pain and its treatment in France BMJ 1995 ;  310 : 1034-1037 [cross-ref]
Bouhassira D., Attal N., Alchaar H., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) Pain 2005 ;  114 : 29-36 [cross-ref]
Organisation Mondiale de la Santé Traitement de la douleur cancéreuse.  Genève: Organisation Mondiale de la Santé (1987). 
Ashby M, Jackson K. When the WHO ladder appears to be failing: approaches to refractory or unstable cancer. In: Sykes N, Fallon MT, Patt RB eds. Clinical Pain Management: Cancer Pain (Rice ASC, Warfield CA, Justins D, Eccleston C series editors).London: Arnold, 2003; 143-55.
Thun M.J., Henley S.J., Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues (review) J Natl Cancer Inst 2002 ;  94 : 252-266 [cross-ref]
Sabino M.A., Ghilardi J.R., Jongen J.L. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2 Cancer Res 2002 ;  62 : 7343-7349
39 McQuay H., Moore A. An evidence-based resource for pain relief.  Oxford: Oxford University Press (1998). 196.
Eisenberg E., Berkey C.S., Carr D.B., et al. Efficacity and safety of nonsteroidal anti-inflammatory drugs for cancer pain: a metaanalysis J Clin Oncol 1994 ;  12 : 2756-2765 [cross-ref]
Kalso E. How different is oxycodone from morphine (Editorial) Pain 2007 ;  132 : 227-228 [cross-ref]
Mercadante S., Bruera E. Opioid switching: a systematic and critical review Cancer Treat Rev 2006 ;  32 : 304-315 [cross-ref]
Portenoy R.K., Hagen N.A. Breakthrough pain: definition, prevalence and characteristics Pain 1990 ;  41 (3) : 273-281 [cross-ref]
Dworkin R.H., O’Connor A.B., Backonja M., et al. Pharmacological management of neuropathic pain: evidence-based recommendations Pain 2007 ;  132 : 237-251 [cross-ref]
Ettinger A.B., Portenoy R.K. The use of corticosteroids in the treatment of symptoms associated with cancer J Pain Symptom Manage 1988 ;  3 : 99-103 [cross-ref]
Grant R., Papadopoulos S.M., Sandler H.M., et al. Metastatic epidural spinal cord compression: current concepts and treatment J Nucl Oncol 1994 ;  19 : 79-92 [cross-ref]
Fulfaro F., Casuccio A., Ticozzi C., et al. The role of biphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials Pain 1998 ;  78 (3) : 157-169 [cross-ref]
48 Wong R., Wiffen P.J. Bisphosphonates for the relief of pain secondary to bone metastases Cochrane Database Syst Rev 2002 ; CD002068
Ruggiero S.J., Rosenberg T.J., Engroff S.L. Osteonecrosis of the jaws associated with use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 2004 ;  62 : 527-534 [cross-ref]
Hoskin P.J. Biphosphonates and radiation therapy for the paliation of metastatic bone disease Cancer Treatment Reviews 2003 ;  29 : 321-327 [cross-ref]
Kreeger L., Hutton-Potts J. The use of calcitonin in the tretment of metastatic bone pain J Pain Symptom Manage 1999 ;  17 (1) : 2-5
Lavelle W., Carl A., Demers Lavelle E., Khaleel M.A. Vertebroplasty and Kyphoplasty Med Clin N Am 2007 ;  91 : 299-314 [inter-ref]
Coumans J.V., Reinhardt M.K., Lieberman I.H. Kyphoplasty for vertebral compression fractures: 1-year clinical outcomes from a prospective study J Neurosurg 2003 ;  99 : 44-50 [cross-ref]
Hoffmann R.T., Jakobs T.F., Trumm C., Weber C., Helmberger T.K., Reiser M.F. Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease J Vasc Interv Radiol 2008 ;  19 : 419-425 [cross-ref]
McQuay H.J., Carrol D., Moore R.A. Radiotherapy for painful bone metastases: a systematic review Clin Oncol 1997 ;  9 : 150-154 [cross-ref]
Roos D.E., Turner S.L., O’Brien P.C., et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastasis (TROG 96 05). Radiother Oncol 2005 ;  75 : 54-63 [cross-ref]
Nilsson S., Franzen L., Parker C., et al. Bone-targeted radium- 223 in symptomatic, hormone refractory prostate cancer: a randomised multicentre placebo-controled phase II study Lancet Oncol 2007 ;  8 : 587-594 [inter-ref]
Tannock I.F., de Wit R., Berry W.R., et al. Doxetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 2004 ;  351 : 1502-1512 [cross-ref]
Galbraith S.M., Duchesnes G.M. Androgens and prostate cancer: biology, pathology and hormonal therapy Eur J Cancer 1997 ;  33 : 545-554 [cross-ref]
Chiras J., Adem C., Vallee J.N., Spelle L., Cormier E., Rose M. Selective intra-arterial chemoembolization of pelvic and spine bone metastases Eur Radiol 2004 ;  14 : 1774-1780
Walker S.M., Cousins M.J. Anesthesiological procedures Cancer Pain : Cambridge University Press (2003).  201-227
Body J.J., Griepp P., Coleman R.E., et al. A phase 1 study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases Cancer 2003 ;  97 (Suppl3) : 887-892 [cross-ref]
Gramooun A., Shorey S., Bashutski J.D., et al. Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast function in vitro Journal of Cellular Biochemistry 2007 ;  102 (2) : 341-352


© 2008  Elsevier Masson SAS. Tous droits réservés.